92591 ⎘
Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
Sub-classes:COMPOSITIONS AND METHODS RELATING TO ATP/P2X7R SIGNALING INHIBITION
#2SUBSTITUTED DIARYL COMPOUND AS WELL AS PREPARATION METHOD AND APPLICATION THEREOF
#3Alkoxy compounds for disease treatment
#4Sphingosine kinase Type 1 inhibitors and uses thereof
#5Conjugated oligoelectrolytes as antimicrobial agents
#6Alkoxy compounds for disease treatment
#7Sphingosine kinase type 1 inhibitors and uses thereof
#8Sphingosine kinase type 1 inhibitors and uses thereof
#9Alkoxy compounds for disease treatment
#104-alkoxy-3-(trifluoromethyl)benzyl alcohol production method
#11Sphingosine kinase type 1 inhibitors and uses thereof
#12Organic compound, three-dimensional organic framework formed by using organic compound, separation sieve and optical layer, which comprise organic framework, and optical device comprising optical layer as optical amplification layer
#13Sphingosine kinase type 1 inhibitors and uses thereof
#14Alkoxy compounds for disease treatment
#15Alkoxy compounds for disease treatment
#16Method of treating pain using an acetaminophen dimer ether-linked through phenolic hydroxyl groups
#17USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS
#18Buprenorphine dimer and its use in treatment of gastrointestinal disorders
#19Sphingosine kinase type 1 inhibitors and uses thereof
#20Organic compounds
#21Methods of treating pain or fever using pharmaceutically active acetaminophen dimers linked through phenolic hydroxyl groups
#22Use of buprenorphine dimer in the treatment of peripheral neuropathic pain
#23Inhibiting neurotransmitter reuptake
#24Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#25Pharmaceutically active dimers linked through phenolic hydroxyl groups
#26Buprenorphine dimer and its use in treatment of gastrointestinal disorders
#27Alkoxy compounds for disease treatment
#28Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
#29Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#30Arylalkene derivatives and use thereof as selective estrogen receptor modulators
#31AMINE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES
#32AMINO DIOL DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS
#33Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#34Venlafaxine assay
#35Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
#36PHENOXYPROPANOL DERIVATIVES AND THEIR USE IN TREATING CARDIAC AND CARDIOVASCULAR DISEASES
#37Sphingosine kinase type 1 inhibitors
#38Alkoxy compounds for disease treatment
#39N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
#40Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#41Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#42FTY720 HALOGENATED DERIVATIVES
#43Sphingosine kinase type 1 inhibitors, and processes for using same
#44Alkoxy compounds for disease treatment
#45FTY720-derived anticancer agents
#46Alkoxy compounds for disease treatment
#47Alkoxy compounds for disease treatment
#48Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#49Bicyclic sphingosine 1-phosphate analogs
#50Inhibitors of cognitive decline
#51Sphingosine kinase type 1 inhibitors, and processes for using same
#52PROCESS FOR THE PREPARATION OF O-DESMETHYL VENLAFAXINE
#53N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
#54Amino alcohol derivative and immunosuppresive agent having same as an active ingredient
#55Alkoxy compounds for disease treatment
#56Amino alcohol derivatives, salts thereof and immunosuppresive agents
#57Amine compound and use thereof for medical purposes
#582-aminobutanol compound and use thereof for medical purposes
#59Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#60BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS
#61Inhibitors of cognitive decline
#62Substituted Hydroxyethylamines
#63Arylamino-arylpropanolamine derivatives and methods of their use
#64Concise β-amino acid synthesis via organocatalytic aminomethylation
#65Aryl amino acid derivatives as inhibitors for treating inflammation
#66Amino-propanol derivatives
#67Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
#68Amino-propanol derivatives
#69Amino alcohol derivative, addition salt thereof, and immunosuppressant
#70Compositions that bind antiterminator RNA and assay for screening for such compositions
#71Nitrogen-containing ligands
#72Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
#733,3′,3″-nitrilotris(1-(naphthalen-2-yloxy)propan-2-ol) as an eco-friendly insecticidal agent against (boisd.)